Biojo Sciences was established to find important therapies for diseases that meet the needs of patients. For many therapeutic innovations to advance to commercialization, it is essential to find the right ingredients in development and funding strategies. Biojo has extensive capabilities to invest in compelling science and overcome the clinical development hurdles – bringing hope to patients and value to stakeholders.
The foundation of our company is to leverage decades of global experience to build efficient and effective solutions in the biopharmaceutical industry. We have brought oncology therapies, biologics, and many other drugs to commercialization. Our aim is to continuously create a structure that delivers early-stage drugs and emerging platforms to patients in need.
Biojo’s team has learned through the years the keys to improving outcomes: culture and integrity. Our culture is shaped around sound collaboration with our team, partners, and network. This gives us a unique advantage in combining both the science and business perspectives, ensuring goals across disciplines are aligned. We also believe the integrity in good science and business practices will transform innovations into valuable therapies.
We look forward to working with passionate scientific and business partners who want to make a meaningful difference in the medicines of tomorrow.
Thank you,
Jenny (Seungyun) Jo
Founder & CEO
Biojo Sciences was established to find important therapies for diseases that meet the needs of patients. For many therapeutic innovations to advance to commercialization, it is essential to find the right ingredients in development and funding strategies. Biojo has extensive capabilities to invest in compelling science and overcome the clinical development hurdles – bringing hope to patients and value to stakeholders.
The foundation of our company is to leverage decades of global experience to build efficient and effective solutions in the biopharmaceutical industry. We have brought oncology therapies, biologics, and many other drugs to commercialization. Our aim is to continuously create a structure that delivers early-stage drugs and emerging platforms to patients in need.
Biojo’s team has learned through the years the keys to improving outcomes: culture and integrity. Our culture is shaped around sound collaboration with our team, partners, and network. This gives us a unique advantage in combining both the science and business perspectives, ensuring goals across disciplines are aligned. We also believe the integrity in good science and business practices will transform innovations into valuable therapies.
We look forward to working with passionate scientific and business partners who want to make a meaningful difference in the medicines of tomorrow.
Thank you,
Jenny (Seungyun) Jo
Founder & CEO
BIO International 2022: Back In-Person
/by Biojo SciencesBIO-Europe 2021
/by Biojo SciencesBIO International Convention 2021
/by Biojo Sciences2021 ASCO Annual Meeting
/by Biojo SciencesA new portfolio model for biotech
/by Biojo SciencesBIO CEO & Investor Conference 2021
/by Biojo SciencesBIO Partnering at JPM 2021
/by Biojo SciencesAmerican Society of Hematology Virtual Meeting 2020
/by Biojo Sciences